• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道细菌组成在帕金森病和其他神经退行性疾病中的变化。

Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.

机构信息

Departement of human medicine, University of Zurich, Winterthurerstrasse 190, 8057 Zürich, Switzerland.

出版信息

Nutrients. 2018 Jun 1;10(6):708. doi: 10.3390/nu10060708.

DOI:10.3390/nu10060708
PMID:29857583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6024871/
Abstract

In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson's disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer's disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of , , Verrucomicrobiaceae and in PD. A decrease of spp., spp., spp., spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.

摘要

近年来,有证据表明神经退行性疾病(NDs)与肠道微生物群落组成密切相关。帕金森病(PD)是这方面研究最深入的神经退行性疾病。在本综述中,我们对已发表的文献进行了系统评估,比较了 PD 患者结肠微生物群落的变化与其他 NDs(包括阿尔茨海默病(AD)、多系统萎缩(MSA)、多发性硬化症(MS)、视神经脊髓炎(NMO)和肌萎缩侧索硬化症(ALS))中观察到的变化。为了增强不同研究的可比性,仅纳入了人类病例对照研究。几项研究表明 PD 患者中 、 、Verrucomicrobiaceae 和 增加。PD 患者中 spp.、 spp.、 spp.、 spp.和 Prevotellaceae 减少。在较低的分类分辨率(如门水平),变化不是疾病特异性的,且不一致。然而,在较高的分类分辨率(如属或种水平),PD 和 MSA(同为α-突触核蛋白病)之间观察到较小的重叠。我们表明,为了确保数据的可重复性和可比性,有必要对样本收集和分析进行标准化。我们还提供了证据,表明在高分类分辨率评估微生物群落组成可以揭示相对丰度的变化,这些变化可能特定于或特征于一种疾病或疾病组,并可能具有区分能力。在对特定细菌对宿主的影响做出明确假设之前,必须研究细菌物种和菌株之间的相互作用以及共同丰度。

相似文献

1
Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.肠道细菌组成在帕金森病和其他神经退行性疾病中的变化。
Nutrients. 2018 Jun 1;10(6):708. doi: 10.3390/nu10060708.
2
Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.神经退行性疾病(帕金森病和阿尔茨海默病)患者与健康对照者的肠道微生物组成:系统评价。
Nutrients. 2023 Oct 13;15(20):4365. doi: 10.3390/nu15204365.
3
What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review.哪些关键肠道微生物群与神经疾病有关?系统综述。
Int J Mol Sci. 2022 Nov 8;23(22):13665. doi: 10.3390/ijms232213665.
4
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.帕金森病和帕金森病药物具有独特的肠道微生物群特征。
Mov Disord. 2017 May;32(5):739-749. doi: 10.1002/mds.26942. Epub 2017 Feb 14.
5
The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.帕金森病中的肠道屏障:现有知识状况。
J Parkinsons Dis. 2019;9(s2):S323-S329. doi: 10.3233/JPD-191707.
6
Neurodegenerative disorders and gut-brain interactions.神经退行性疾病与肠脑相互作用。
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI143775.
7
Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.肠道微生物群及其在帕金森病中的影响:西方患者的系统评价
Neurol Int. 2023 Jun 13;15(2):750-763. doi: 10.3390/neurolint15020047.
8
The gut microbiome in Parkinson's disease: A culprit or a bystander?帕金森病中的肠道微生物组:罪魁祸首还是旁观者?
Prog Brain Res. 2020;252:357-450. doi: 10.1016/bs.pbr.2020.01.004. Epub 2020 Mar 5.
9
A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.帕金森病患者与对照受试者的微生物组初步研究,以及芬戈莫德和芬戈莫德-甲氧基在帕金森病和多系统萎缩小鼠模型中的治疗效果。
J Parkinsons Dis. 2020;10(1):185-192. doi: 10.3233/JPD-191693.
10
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?肠内微生物群、肠道黏膜屏障和肠神经免疫系统之间的相互作用:通往神经退行性疾病的共同途径?
Acta Neuropathol. 2018 Sep;136(3):345-361. doi: 10.1007/s00401-018-1856-5. Epub 2018 May 24.

引用本文的文献

1
The engineered probiotic strain Lactococcus lactis MG1363-pMG36e-GLP-1 regulates microglial polarization and gut dysbiosis in a transgenic mouse model of Parkinson's disease.工程益生菌乳酸乳球菌MG1363-pMG36e-GLP-1在帕金森病转基因小鼠模型中调节小胶质细胞极化和肠道菌群失调。
Neural Regen Res. 2026 Mar 1;21(3):1211-1221. doi: 10.4103/NRR.NRR-D-24-00702. Epub 2025 Jan 13.
2
FLZ attenuates Parkinson's disease pathological damage by increasing glycoursodeoxycholic acid production down-regulating .FLZ通过增加甘氨脱氧胆酸的生成和下调(此处原文缺失具体下调内容)来减轻帕金森病的病理损伤。
Acta Pharm Sin B. 2025 Feb;15(2):973-990. doi: 10.1016/j.apsb.2024.10.011. Epub 2024 Oct 30.
3

本文引用的文献

1
Relationship between the gut microbiome and brain function.肠道微生物组与大脑功能的关系。
Nutr Rev. 2018 Jul 1;76(7):481-496. doi: 10.1093/nutrit/nuy009.
2
New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.源自生物活性天然分子的新型治疗药物:肠道微生物群代谢在神经退行性疾病中的作用
Curr Drug Metab. 2018;19(6):478-489. doi: 10.2174/1389200219666180404094147.
3
Toll-Like Receptors: Regulators of the Immune Response in the Human Gut.Toll 样受体:人类肠道中免疫反应的调节剂。
Gut microbiota and microRNAs as biomarkers in Parkinson's disease: early identification, diagnostic and potential treatments.
肠道微生物群和微小RNA作为帕金森病的生物标志物:早期识别、诊断及潜在治疗方法
Mol Cell Biochem. 2025 Mar 31. doi: 10.1007/s11010-025-05271-6.
4
Impact of 16S rRNA on Intestinal Flora Alterations and Early Diagnosis in Early Alzheimer's Disease Patients.16S rRNA对早期阿尔茨海默病患者肠道菌群改变及早期诊断的影响
Actas Esp Psiquiatr. 2025 Mar;53(2):208-221. doi: 10.62641/aep.v53i2.1682.
5
SVHRSP protects against rotenone-induced neurodegeneration in mice by inhibiting TLR4/NF-κB-mediated neuroinflammation via gut microbiota.SVHRSP通过肠道微生物群抑制TLR4/NF-κB介导的神经炎症,从而保护小鼠免受鱼藤酮诱导的神经退行性变。
NPJ Parkinsons Dis. 2025 Mar 6;11(1):43. doi: 10.1038/s41531-025-00892-6.
6
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases.微生物特洛伊木马:毒力因子在神经退行性疾病中扮演关键角色
Molecules. 2025 Feb 4;30(3):687. doi: 10.3390/molecules30030687.
7
Emerging mechanisms of organ crosstalk: The role of oxylipins.器官串扰的新机制:氧化脂质的作用。
Nutr Bull. 2025 Mar;50(1):12-29. doi: 10.1111/nbu.12726. Epub 2024 Dec 10.
8
IMPACT: interpretable microbial phenotype analysis via microbial characteristic traits.IMPACT:通过微生物特征进行可解释的微生物表型分析
Bioinformatics. 2024 Dec 26;41(1). doi: 10.1093/bioinformatics/btae702.
9
Gut bacteria: an etiological agent in human pathological conditions.肠道细菌:人类病理条件的病因。
Front Cell Infect Microbiol. 2024 Oct 8;14:1291148. doi: 10.3389/fcimb.2024.1291148. eCollection 2024.
10
Housing RCS rats under specific pathogen-free conditions mildly ameliorates retinal degeneration and alters intestine microbiota.在特定病原体-free条件下饲养RCS大鼠可轻度改善视网膜变性并改变肠道微生物群。
Sci Rep. 2024 Sep 16;14(1):21583. doi: 10.1038/s41598-024-70960-z.
Nutrients. 2018 Feb 13;10(2):203. doi: 10.3390/nu10020203.
4
Microbiota Signaling Pathways that Influence Neurologic Disease.微生物群信号通路对神经疾病的影响。
Neurotherapeutics. 2018 Jan;15(1):135-145. doi: 10.1007/s13311-017-0598-8.
5
The Gut Microbiome in Neuromyelitis Optica.视神经脊髓炎中的肠道微生物组。
Neurotherapeutics. 2018 Jan;15(1):92-101. doi: 10.1007/s13311-017-0594-z.
6
Live Faecalibacterium prausnitzii Does Not Enhance Epithelial Barrier Integrity in an Apical Anaerobic Co-Culture Model of the Large Intestine.活粪普拉梭菌(Faecalibacterium prausnitzii)在大肠的顶端厌氧共培养模型中不会增强上皮屏障完整性。
Nutrients. 2017 Dec 12;9(12):1349. doi: 10.3390/nu9121349.
7
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.挠动你肚子的微生物:肠道-大脑轴在帕金森病中的重要性
Curr Behav Neurosci Rep. 2017;4(4):361-368. doi: 10.1007/s40473-017-0129-2. Epub 2017 Nov 8.
8
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.帕金森病的进展与肠道微生物群失调有关:两年随访研究。
PLoS One. 2017 Nov 1;12(11):e0187307. doi: 10.1371/journal.pone.0187307. eCollection 2017.
9
Altered gut microbiome and metabolome in patients with multiple system atrophy.多系统萎缩患者肠道微生物群和代谢组的改变
Mov Disord. 2018 Jan;33(1):174-176. doi: 10.1002/mds.27203. Epub 2017 Oct 30.
10
The prodromal microbiome.前驱微生物群
Mov Disord. 2018 Jan;33(1):5-7. doi: 10.1002/mds.27197. Epub 2017 Oct 30.